Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): impact on quality of life and therapeutic options.
about
Complementary and Alternative Therapies in Amyotrophic Lateral SclerosisPatient-Perceived Outcomes and Quality of Life in ALSAdiponectin levels in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients: possible influence on neuroinflammation?Noninvasive ventilation reduces energy expenditure in amyotrophic lateral sclerosis.Defining Swallowing-Related Quality of Life Profiles in Individuals with Amyotrophic Lateral SclerosisAlternative Fuels in Epilepsy and Amyotrophic Lateral Sclerosis.Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic TreatmentsPercutaneous endoscopic gastrostomy, body weight loss and survival in amyotrophic lateral sclerosis: a population-based registry study.Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial.Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study.What is "Hyper" in the ALS Hypermetabolism?Motoneuron Disease: Clinical.Respiratory and nutritional support in amyotrophic lateral sclerosis.Amyotrophic lateral sclerosisALSUntangled 41: “Eric Is Winning”THEME 4 RESPIRATORY AND NUTRITIONAL MANAGEMENTMaximizing the Survival of Amyotrophic Lateral Sclerosis Patients: Current Perspectives
P2860
Q26777929-1A4DFEF8-22BE-4E5E-BCDA-0549CC93DADBQ26998579-27E2836F-CFA8-4DF7-A179-BA61EDF3F33AQ33582007-FB84D0D1-AC16-4760-8943-F0D84ADCFF0BQ35089202-47C69F28-86F7-4A0B-BA18-172F45208865Q36913504-898F07DA-95A2-4A33-9400-844847FB5F52Q39014987-E983129B-115A-43BE-984D-11C89E2B856CQ39101800-B9BB3990-C2E8-47CD-A3B7-7C979ADA5F0EQ40385575-310289A0-2B47-4CA2-86C3-90335A81D151Q41009555-4E9DFB74-F9F9-412A-BB94-6336A2E3C438Q41531607-3A18208B-6B0F-44C2-B67B-E1E4059C8F55Q42730688-3B2DA358-8E83-4AA4-9928-C3FF8DF6DAAFQ45869420-F59BBF1B-A456-49C4-983C-0944E97F0107Q46636879-6320B306-CE6A-42DE-8C60-D94274E6C52AQ56531747-8576BFEA-9388-4196-8C29-AF49E95353CFQ57464259-20AEDE05-825F-4CD0-8DD2-9F45BC059CCEQ58153017-24CF5809-93C4-4532-BEEB-035E1D1882D2Q58787868-78257EDD-74FE-41F3-936C-D5E2016DFD62
P2860
Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): impact on quality of life and therapeutic options.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Weight loss, dysphagia and sup ...... life and therapeutic options.
@ast
Weight loss, dysphagia and sup ...... life and therapeutic options.
@en
Weight loss, dysphagia and sup ...... life and therapeutic options.
@nl
type
label
Weight loss, dysphagia and sup ...... life and therapeutic options.
@ast
Weight loss, dysphagia and sup ...... life and therapeutic options.
@en
Weight loss, dysphagia and sup ...... life and therapeutic options.
@nl
prefLabel
Weight loss, dysphagia and sup ...... life and therapeutic options.
@ast
Weight loss, dysphagia and sup ...... life and therapeutic options.
@en
Weight loss, dysphagia and sup ...... life and therapeutic options.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Weight loss, dysphagia and sup ...... life and therapeutic options.
@en
P2093
Antonia Zapf
Katja Kollewe
Melanie Hendricks
Sonja Körner
P2860
P2888
P356
10.1186/1471-2377-13-84
P577
2013-07-12T00:00:00Z
P5875
P6179
1007282776